Zinger Key Points
- HealthEquity reports fourth-quarter revenue of $311.82 million, beating estimates of $306.05 million.
- HealthEquity reports fourth-quarter adjusted earnings of 69 cents per share, missing estimates of 72 cents per share.
- Next: Get access to a new market-moving chart every day featuring a stock flashing clear technical signals. See today's pick now.
HealthEquity Inc HQY reported fourth-quarter financial results after the market close on Tuesday and shares are sinking. Here’s a rundown of the report.
- Q4 Revenue: $311.82 million, versus estimates of $306.05 million
- Q4 Adjusted EPS: 69 cents, versus estimates of 72 cents
Total revenue was up 19% on a year-over-year basis. The company reported 9.9 million health savings accounts (HSAs) as of Jan. 31, up 14% year-over-year. Total accounts came in at 17 million as of Jan. 31. Total HSA assets were up 27% year-over-year to $32.1 billion.
HealthEquity said it repurchased 1.4 million shares of its common stock in fiscal 2025 for $122.2 million. The company had $177.8 million remaining under its buyback as of Jan. 31.
“Team Purple finished fiscal ‘25 in strong fashion, with record revenues and major strides in advancing our strategic initiatives, allowing us to provide our outlook for an even stronger fiscal ‘26,” said Scott Cutler, president and CEO of HealthEquity.
“With a focus on Member First Secure Mobile Experiences, we are executing against our 3Ds strategy to Deepen partnerships, Deliver remarkable experiences, and Drive member outcomes for our Clients, Network Partners, and members.”
Outlook: HealthEquity expects fiscal year 2026 revenue of $1.28 billion to $1.305 billion versus estimates of $1.301 billion. The company anticipates full-year earnings of $3.57 to $3.74 per share versus estimates of $3.71 per share.
The guidance came in below estimates at the midpoint, which appears to be weighing on shares after hours.
HealthEquity executives will further discuss the quarter on a call with investors and analysts at 4:30 p.m. ET.
HQY Price Action: HealthEquity shares were down 12.46% after hours, trading at $89 at the time of publication Tuesday, per Benzinga Pro.
Read Next:
Photo: Shutterstock.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.